Diagnostics Co. Hycor Unloads Unit In Sale To PE Group

Law360, New York (February 20, 2013, 1:11 PM EST) -- Hycor Biomedical Inc., the private-equity backed maker of in vitro diagnostic equipment, handed off its urinalysis unit to an investor group that includes One Rock Capital Partners LLC, Laurel Crown Partners LLC and StoneCreek Capital Inc., the California company said Wednesday.

The parties did not disclose the financial terms of the transaction, which covers the urinalysis employees and assets, including Hycor's flagship Kova product line. The sale lifts Hycor ownership from health care-focused investment firm Linden LLC, which bought the company from Agilent Technologies Inc. in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.